Get notified when ELOX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Critical incident detected

Existential event · Existential event

Time-sensitive event — see the red-flag panel below for the source-quoted detail.

Red Flags Detected

  • Going Concern (new) — The company explicitly states substantial doubt about its ability to continue as a going concern, and the auditor's report includes an explanatory paragraph regarding going concern.
  • Material Weakness (new) — The company has identified a material weakness in its internal control over financial reporting.
  • Delisted (new) — The company's stock was delisted from Nasdaq in October 2023 for failing to meet the minimum market value requirement, indicating prior financial distress.
  • Single-source Supplier (new) — The company relies on a single-source supplier for raw materials, increasing supply disruption risk.
  • Expire In 2031 (new) — Core patent protection for lead compound exaluren expires in 2031, limiting exclusivity.
ELOX ELOX S-1/A

ELOX files S-1/A for $30.5M primary offering at $11.00/share, with $54.2M net proceeds and $43.1M implied market cap

Filed June 4, 2026 · ~2 min read

Key Changes

  • high

    ELOX is offering 2,730,000 shares of common stock plus pre-funded warrants to purchase up to 2,770,000 shares at $11.00 per share (preliminary).

    The Offering verify on EDGAR →
  • high

    The company estimates net proceeds of approximately $54.2 million, after underwriting discounts and expenses, based on the assumed $11.00 price.

    Use of Proceeds verify on EDGAR →
  • high

    ELOX plans to use $13.2 million for a Phase 2b trial in Alport syndrome and $19.2 million for a Phase 2 trial in ADPKD, with the remainder for working capital.

    Use of Proceeds verify on EDGAR →

5 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (PURR 10-K) is open in full — no account needed.

Partner

Trade ELOX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 31, 2026 · How we verify